Feedback

Drugs for treating myocardial fibrosis

Affiliation
Hubei Key Laboratory of Diabetes and Angiopathy ,Medicine Research Institute ,Xianning Medical College ,Hubei University of Science and Technology ,Xianning ,China
Ren, Zhanhong;
Affiliation
Hubei Key Laboratory of Diabetes and Angiopathy ,Medicine Research Institute ,Xianning Medical College ,Hubei University of Science and Technology ,Xianning ,China
Zhang, Zixuan;
Affiliation
Hubei Key Laboratory of Diabetes and Angiopathy ,Medicine Research Institute ,Xianning Medical College ,Hubei University of Science and Technology ,Xianning ,China
Ling, Li;
Affiliation
Hubei Key Laboratory of Diabetes and Angiopathy ,Medicine Research Institute ,Xianning Medical College ,Hubei University of Science and Technology ,Xianning ,China
Liu, Xiufen;
Affiliation
School of Mathematics and Statistics ,Hubei University of Science and Technology ,Xianning ,China
Wang, Xin

Myocardial fibrosis, which is a common pathological manifestation of many cardiovascular diseases, is characterized by excessive proliferation, collagen deposition and abnormal distribution of extracellular matrix fibroblasts. In clinical practice, modern medicines, such as diuretic and β receptor blockers, and traditional Chinese medicines, such as salvia miltiorrhiza and safflower extract, have certain therapeutic effects on myocardial fibrosis. We reviewed some representative modern medicines and traditional Chinese medicines (TCMs) and their related molecular mechanisms for the treatment of myocardial fibrosis. These drugs alleviate myocardial fibrosis by affecting related signaling pathways and inhibiting myocardial fibrosis-related protein synthesis. This review will provide more references and help for the research and treatment of myocardial fibrosis.

Cite

Citation style:
Could not load citation form.

Access Statistic

Total:
Downloads:
Abtractviews:
Last 12 Month:
Downloads:
Abtractviews:

Rights

License Holder: Copyright © 2023 Ren, Zhang, Ling, Liu and Wang.

Use and reproduction: